YUKON CHOICE SWIFT - ARCSA Registration 8e7c61ae1a088b1726d55a971fe38480
Access comprehensive regulatory information for YUKON CHOICE SWIFT in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID 8e7c61ae1a088b1726d55a971fe38480 and manufactured by TRANSLUMINA THERAPEUTICS LLP. The device was registered on April 30, 2020.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
YUKON CHOISE SWIFT ENDOPROSTHESIS IS INDICATED TO TREAT PATIENTS SUFFERING FROM CORONARY ARTERY STENOSIS. IT IS INDICATED TO INCREASE THE CORONARY LUMINAL DIAMETER IN PATIENTS WITH ISCHEMIC HEART DISEASE DUE TO LESIONS THAT HAVE A LENGTH LESS THAN OR EQUAL TO 48 MM IN NATIVE CORONARY ARTERIES WITH A REFERENCE DIAMETER RANGING FROM 2.0 MM TO 4.0 MM

